Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

About: 3,4-Methylenedioxy-N-propylamphetamine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

3,4-Methylenedioxy-N-propylamphetamine (MDPR, "Phantom") is a lesser-known psychedelic drug and a substituted amphetamine. MDPR was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown. MDPR is a promoter; by itself it has almost no effects on the mind, but it promotes the effects of hallucinogens, similarly to the closely related MDPH.

thumbnail
Property Value
dbo:abstract
  • 3,4-Methylenedioxy-N-propylamphetamine (MDPR, "Phantom") is a lesser-known psychedelic drug and a substituted amphetamine. MDPR was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown. MDPR is a promoter; by itself it has almost no effects on the mind, but it promotes the effects of hallucinogens, similarly to the closely related MDPH. Shulgin reported that 160 mg of MDPR strongly enhanced the effects of a small (60 μg) dose of LSD, and that similar enhancement of hallucinogenic effect was noted when mixing MDPR with other drugs such as psilocybin, mescaline, 2C-B, and 2C-T-7. The reason for this synergistic action of MDPR has not been elucidated. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPR other than what is written in PiHKAL. (en)
dbo:iupacName
  • N-[1-(2H-1,3-Benzodioxol-5-yl)propan-2-yl]propan-1-amine (en)
dbo:thumbnail
dbo:wikiPageID
  • 10106270 (xsd:integer)
dbo:wikiPageLength
  • 2202 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1075993827 (xsd:integer)
dbo:wikiPageWikiLink
dbp:imagefile
  • Methylenedioxypropylamphetamine.svg (en)
dbp:imagesize
  • 200 (xsd:integer)
dbp:name
  • 34 (xsd:integer)
dbp:pin
  • N-[1-propan-2-yl]propan-1-amine (en)
dbp:verifiedrevid
  • 379537419 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • 3,4-Methylenedioxy-N-propylamphetamine (MDPR, "Phantom") is a lesser-known psychedelic drug and a substituted amphetamine. MDPR was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown. MDPR is a promoter; by itself it has almost no effects on the mind, but it promotes the effects of hallucinogens, similarly to the closely related MDPH. (en)
rdfs:label
  • 3,4-Methylenedioxy-N-propylamphetamine (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • 3,4-Methylenedioxy-N-propylamphetamine (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License